
Gencor’s PEA ingredient gains TGA approval, end product to hit Australian market early this year
Gencor has gained the Therapeutic Goods Administration (TGA) approval for its palmitoylethanolamide (PEA) for use as an active ingredient in listed medicines in Australia.